Clinical Trials List
2021-07-26 - 2025-09-08
Phase II
Terminated4
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- - - 無
- Chien-Chin Lin 無
- - - 無
- Huai-Hsuan Huang 無
- SHAN-CHI YU 無
- Wen-Chien Chou 無
- KUAN-YIN KO 無
- Chieh-Lung Cheng 無
- Shang-Ju Wu 無
- MING YAO 無
- BANG-BIN CHEN 無
- CHENG-HONG TSAI 無
- 田豐銘 無
- HSIN-AN HOU 無
- Jih-Luh Tang 無
- 劉高郎 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Chung Kao 無
- 高小雯 無
- Tung-Liang Lin 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
148 participants
